Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03596671 · ClinicalTrials.gov registry record · NA
BlueWind RENOVA iStim™ System for the Treatment of OAB
A NA study, sponsored by BlueWind Medical.
- Completed
- Registry status
- NA
- Development phase
- 282
- Enrollment target
NCT03596671 is a NA study that has completed, run by BlueWind Medical. The registered enrollment target is 282 participants.
The verdict
NCT03596671, a NA study, has completed, sponsored by BlueWind Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 282 participants
- Enrollment target
Study Summary
The OASIS study is prospective, interventional, multi-center study to evaluate the safety and efficacy of the BlueWind RENOVA iStim™ implantable tibial neuromodulation System for the treatment of patients diagnosed with overactive bladder.
Interventions
- DEVICE RENOVA iStim™ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2019-06-12 |
| Est. Completion | 2025-01-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03596671
The ClinicalTrials.gov registry entry for NCT03596671 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BlueWind Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RENOVA iStim™ System is the first listed.
NCT03596671 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03596671 about?
NCT03596671 is a clinical study titled "BlueWind RENOVA iStim™ System for the Treatment of OAB". The OASIS study is prospective, interventional, multi-center study to evaluate the safety and efficacy of the BlueWind RENOVA iStim™ implantable tibial neuromodulation System for the treatment of patients diagnosed with overactive bladder.
What is the current status of trial NCT03596671?
This trial is currently completed. It is a NA study. The enrollment target is 282 participants. The study started on 2019-06-12. Estimated completion is 2025-01-24.
What interventions are being tested in trial NCT03596671?
The interventions under investigation include: RENOVA iStim™ System (DEVICE).
Who is sponsoring clinical trial NCT03596671?
This trial is sponsored by BlueWind Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.